Filing Details
- Accession Number:
- 0001415889-24-022033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-22 16:30:15
- Reporting Period:
- 2024-08-20
- Accepted Time:
- 2024-08-22 16:30:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-08-20 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-08-20 | 946 | $341.76 | 2,784 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 362 | $343.10 | 2,422 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 138 | $343.64 | 2,284 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 220 | $345.66 | 2,064 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 640 | $347.48 | 1,424 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 660 | $348.22 | 764 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 151 | $349.47 | 613 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 237 | $350.61 | 376 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 173 | $351.81 | 203 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-20 | 73 | $353.17 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-08-21 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-08-21 | 340 | $346.34 | 3,390 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-21 | 837 | $347.91 | 2,553 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-21 | 339 | $348.76 | 2,214 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-21 | 390 | $350.10 | 1,824 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-21 | 459 | $351.47 | 1,365 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-21 | 1,164 | $352.57 | 201 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-21 | 71 | $352.98 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2024-08-20 | 3,600 | $0.00 | 3,600 | $129.49 |
Common Stock | Stock Options | Disposition | 2024-08-21 | 3,600 | $0.00 | 3,600 | $129.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,669 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
11,069 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 245,909 | Indirect | By Trust |
Common Stock | 28,170 | Indirect | By Trust |
Common Stock | 324,518 | Indirect | By Trust |
Common Stock | 45,596 | Indirect | By Trust |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $341.28 to $342.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $342.59 to $343.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $345.25 to $345.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $346.80 to $347.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $347.90 to $348.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $349.00 to $349.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $350.49 to $350.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $351.49 to $352.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $346.07 to $346.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $347.23 to $348.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $348.28 to $349.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $349.43 to $350.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $350.93 to $351.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $351.97 to $352.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.